HEALTH● LOWJul 10 · Jul 10, 2026, 11:29 AM
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Seeking Alpha Tech
A partner of GSK, Hansoh, has successfully completed a late-stage trial for a lung cancer drug in China. This development marks progress in the pharmaceutical industry's efforts to treat lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH35m agoKarnataka Health Minister urges public to use alternatives as 108 ambulance workers threaten strike from October 14 nightThe HinduHEALTH42m ago"Global health is a team sport": World Health Summit in BerlinEuroNews [en]HEALTH57m agoSPECIAL REPORT: Insecurity exposes Zamfara communities to recurring cholera outbreaksPremium TimesHEALTH1h agoAt NIFST AGM: NAFDAC DG charges food scientists on food safety, qualityVanguard Nigeria